SCHEMBL7616374

SCHEMBL7616374

O=c1cccccc1-c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.65
HDAC2 Q92769 1/20 0.65
HDAC8 Q9BY41 1/20 0.65
HDAC6 Q9UBN7 1/20 0.65
LMNA P02545 1/20 0.52
MAPT P10636 1/20 0.52
HTT P42858 1/20 0.52
ALDH1A1 P00352 5/20 0.48
HSD17B10 Q99714 2/20 0.48
HPGD P15428 1/20 0.48
BCL2L1 Q07817 1/20 0.48
CYP2A6 P11509 1/20 0.48
MAPK1 P28482 1/20 0.48
MGLL Q99685 1/20 0.46
CDC25B P30305 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
BCAT2 O15382 1/20 0.44
BACE1 P56817 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15437890 0.97 HDAC4 (0.62) HDAC4HDAC2HDAC8HDAC6LMNA
SCHEMBL5389905 0.97 HDAC4 (0.62) HDAC4HDAC2HDAC8HDAC6LMNA
SCHEMBL10505011 0.83 HDAC4 (0.48) HDAC4HDAC2HDAC8HDAC6LMNA
SCHEMBL21471576 0.79 HDAC4 (1.00) HDAC4HDAC2HDAC8HDAC6LMNA
SCHEMBL2442343 0.79 GSTP1 (0.62) HDAC4HDAC2HDAC8HDAC6LMNA
SCHEMBL7914987 0.79 LMNA (0.55) HDAC4HDAC2HDAC8HDAC6LMNA
SCHEMBL10481639 0.78 HDAC4 (0.77) HDAC4HDAC2HDAC8HDAC6LMNA
SCHEMBL16812115 0.78 HDAC4 (0.71) HDAC4HDAC2HDAC8LMNAMAPT
SCHEMBL7905187 0.78 ALDH1A1 (0.54) HDAC4HDAC2HDAC8HDAC6LMNA
SCHEMBL21447 0.77 ALDH1A1 (0.61) HDAC4HDAC2HDAC8HDAC6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9790158-B2 Substituted tropolone derivatives and methods of use UNIVERSITY OF CONNECTICUT (US) 2017-10-17 US disclosed
US-9790158-B2 Substituted tropolone derivatives and methods of use UNIVERSITY OF CONNECTICUT (US) 2017-10-17 US disclosed
US-20150166448-A1 Substituted Tropolone Derivatives and Methods of Use UNIVERSITY OF CONNECTICUT 2015-06-18 US disclosed
US-20150166448-A1 Substituted Tropolone Derivatives and Methods of Use UNIVERSITY OF CONNECTICUT 2015-06-18 US disclosed
EP-0863890-B1 5-AMIDOMETHYL ALPHA, BETHA-SATURATED AND -UNSATURATED 3-ARYL BUTYROLACTONE ANTIBACTERIAL AGENTS UPJOHN CO (US) 2002-12-04 EP disclosed
EP-0872903-B1 Method for making hydrogen storage alloy powder and electrode comprising the alloy powder SHINETSU CHEMICAL CO (JP) 2001-10-04 EP disclosed
US-6277519-B1 QUENCHING AN ALLOY MELT; COMMINUTION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2001-08-21 US disclosed
US-6096144-A TREATING WITH ACIDIC OR ALKALINE SOLUTION OF CONJUGATED UNSATURATED COMPOUND WITH AT LEAST 5 BONDS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2000-08-01 US disclosed
US-5858571-A TREATING A PULVERIZED HYDROGEN ABSORBING ALLOY WITH A SOLUTION COMPRISING A CONJUGATED UNSATURATED COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 1999-01-12 US disclosed
EP-0872903-A1 Method for making hydrogen storage alloy powder and electrode comprising the alloy powder Shin-Etsu Chemical Co., Ltd. (JP) 1998-10-21 EP disclosed
EP-0863890-A1 5-AMIDOMETHYL ALPHA, BETHA-SATURATED AND -UNSATURATED 3-ARYL BUTYROLACTONE ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 1998-09-16 EP disclosed
US-5708169-A BACTERICIDES FOR TREATMENT OF GRAM POSITIVE INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1998-01-13 US disclosed
WO-1997010235-A1 5-AMIDOMETHYL α, β-SATURATED AND -UNSATURATED 3-ARYL BUTYROLACTONE ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 1997-03-20 WO disclosed
EP-0172427-B1 PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER Shin-Etsu Chemical Co., Ltd. (JP) 1989-07-05 EP disclosed
US-4758639-A Process for production of vinyl polymer SHIN-ETSU CHEMICAL CO., LTD. (JP) 1988-07-19 US disclosed
US-4757124-A Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments SHIN-ETSU CHEMICAL CO., LTD. (JP) 1988-07-12 US disclosed
EP-0172427-A2 Process for production of vinyl chloride polymer Shin-Etsu Chemical Co., Ltd. (JP) 1986-02-26 EP disclosed
US-4539230-A COATING WALLS WITH A CHELATE COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 1985-09-03 US disclosed
EP-0126991-A1 A method for preventing deposition of polymer scale and a coating agent therefor Shin-Etsu Chemical Co., Ltd. (JP) 1984-12-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166448-A1 Substituted Tropolone Derivatives and Methods of Use HDAC5, HDAC4, HDAC7 HDAC4 2/4885HDAC2 10/4885HDAC8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.